TLR-based immune adjuvants
Top Cited Papers
- 14 August 2010
- Vol. 29 (17) , 3341-3355
- https://doi.org/10.1016/j.vaccine.2010.08.002
Abstract
No abstract availableKeywords
This publication has 258 references indexed in Scilit:
- The TLR9 agonist CpG fails to enhance the acquisition of Plasmodium falciparum-specific memory B cells in semi-immune adults in MaliVaccine, 2009
- A randomized and controlled Phase 1 study of the safety and immunogenicity of the AMA1-C1/Alhydrogel®+CPG 7909 vaccine for Plasmodium falciparum malaria in semi-immune Malian adultsVaccine, 2009
- Toll-like receptor 2 on inflammatory monocytes induces type I interferon in response to viral but not bacterial ligandsNature Immunology, 2009
- Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young womenPublished by Elsevier ,2009
- Recognition of microorganisms and activation of the immune responseNature, 2007
- Systemic but not mucosal immunity induced by AVA prevents inhalational anthraxMicrobes and Infection, 2007
- The Lyme vaccine: a cautionary taleEpidemiology and Infection, 2006
- Pathogen Recognition and Innate ImmunityCell, 2006
- Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848Nature Immunology, 2002
- Structural requirements of the rIn·rCn complex for Induction of human interferonJournal of Molecular Biology, 1972